机译:转移至口面部的肾细胞癌:减轻症状和控制疾病进展的新方法
Head & Neck Centre, University College Hospital, 1st Floor East Wing, 250 Euston Road, London NW12PG, United Kingdom;
UCLH Head and Neck Centre, London, United Kingdom,Unit of Oral and Maxillofacial Surgery, UCL Eastman Dental Institute, London, United Kingdom,Department of Surgery, University College London Medical School, London, United Kingdom;
UCLH Head and Neck Centre, London, United Kingdom,Department of Surgery, University College London Medical School, London, United Kingdom;
UCLH Head and Neck Centre, London, United Kingdom;
UCLH Head and Neck Centre, London, United Kingdom,Unit of Oral and Maxillofacial Surgery, UCL Eastman Dental Institute, London, United Kingdom,Department of Surgery, University College London Medical School, London, United Kingdom;
metastatic; renal cell carcinoma; orofacial region; alleviate symptoms; disease control;
机译:生物有效剂量对转移性肾细胞癌症状进展的时间的影响。
机译:重要组癌症患者癌症治疗肾症状指数疾病相关症状的功能评估差异
机译:帕佐帕尼在疾病进展后采用其他靶向疗法治疗转移性透明细胞肾细胞癌患者的结果
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
机译:异常的疾病/症状关联:合并有未知的原发性和肾细胞癌的肾脏转移性黑色素瘤
机译:用疾病进展与其他靶向疗法患者用Pazopanib治疗转移性透明细胞肾细胞癌的结果